Selicrelumab (RG-7876) is an antibody targeting CD40 with potential anti-tumor activity that induces changes in the tumor microenvironment in patients with resectable pancreatic cancer and may be used to study pancreatic cancer.
Purity:
95.20%
CAS Number:
[1622140-49-1]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted